Bio-Innovation Initiatives

Today, I’m thrilled to share what I believe is the biggest breakthrough in microbiome science for a decade. Nature Magazine, the world's most influential scientific journal, has just published a scientific paper by ZOE's scientists, establishing the first reliable, repeatable, global way to measure the health of an individual’s gut microbiome. It represents the culmination of eight years of work at ZOE. Scientists have been trying to solve this puzzle for more than 20 years, right back to when they first discovered how important our gut microbes are for our health. It’s been achieved only because more than 34,000 ZOE members took part in this research. We’ve known for a long time that the microbiome is linked to cholesterol, inflammation, blood sugar control and even how we store fat. But we’ve never had a clear, evidence-based way to measure how healthy a microbiome actually is. This analysis finally delivers it, revealing a global ranking of microbes that works across populations, diets and environments. The insights are remarkable. Among the top 50 “good microbes” linked with better health, 22 were completely unknown to science until today, and most of the others have never been successfully grown in a lab. We also discovered clear links between these good microbes and health outcomes: healthy individuals carry around 3.6 more of these beneficial species, and people at a healthy weight carry about 5.2 more than those living with obesity. We also found a strong connection to diet. People eating healthier diets consistently have microbiomes that score better on this ranking. What we eat shapes our gut health, and now we can measure this relationship with unprecedented clarity. ZOE was created to enable microbiome research at a scale that traditional science has been unable to fund, and use this research to create actionable advice that can transform our gut health. This is a major milestone in that journey. I’m delighted to say that as a result, this breakthrough science is immediately available for the public to investigate their own microbiome through ZOE’s new Gut Health Test in the UK, and this is coming soon in the US. You can now receive not only a reliable measurement of how healthy your microbiome is as you change their diet, but also discover the health of clusters of gut microbes in your gut affecting metabolism, inflammation and more. To all our amazing ZOE members who have participated in our science: you made this possible. You are transforming our understanding of the microbiome. Thank you so much. I hope you feel as proud and excited as I do. I should note that your research is now published in Nature, which is the ultimate scientific accolade, and you can definitely brag about that with your friends! If you think this science could help others understand their health, I’d love for you to share it. You’ll find links to more details from our findings and access to the paper in the comments.

Scientists have discovered a molecular motor inside bacteria that looks exactly like the electric motors we use every day. These are not just any motors; they are made of protein complexes and can spin both clockwise and counterclockwise, enabling bacteria like sperm to move similarly to man-made electric motor-powered machines. What's truly remarkable is how nature and human engineers independently developed similar designs for rotary motion. But here's the cool part: researchers are using cryo-electron microscopy to see these motors in insane detail. Basically, they flash-freeze bacteria samples and bombard them with electrons, capturing thousands of 2D images. As described by one of the researchers, it's just like taking thousands of iPhone Live Photos of something impossibly small. Now, then, they use AI to reconstruct these 2D images into 3D models. And what's mind-blowing is how the resolution is so good they can even see individual atoms and their bonds. However, why does this all matter?? well, understanding these spinning motors could revolutionize how we fight diseases. instead of killing bacteria, we might just stop them from moving with what these researchers call "lethargy biotics". Where you treat infections by making bacteria too lazy to spread or create super-precise drug delivery systems based on these natural motors.

One twin watches her body fail while her identical sister stays perfectly healthy. Scientists just discovered the difference lives in their gut. Two bacteria turning the brain against itself. Think about that. German researchers recruited 81 pairs of identical twins where only one twin had MS—stripping away genetic confusion to expose what really causes MS. They discovered over 50 bacterial differences between affected and unaffected twins, with Eisenbergiella tayi and Lachnoclostridium species standing out as potential MS triggers. Traditional MS Reality: ↳ 2.8 million people affected worldwide ↳ Cause labeled "multifactorial mystery" ↳ Immune suppressants manage symptoms ↳ Progressive disability often inevitable The Microbiome Discovery: ↳ Specific bacteria enriched in MS twins ↳ Transplanted gut microbes trigger disease in mice ↳ Female mice particularly susceptible ↳ Direct gut-brain-immune connection proven But here's what grabbed me: When researchers transplanted gut bacteria from MS twins into germ-free mice, the animals developed MS-like disease. Not from genetics. Not from environment. From microbes alone. The bacteria from healthy twins? Protected the mice. Even more striking: Eisenbergiella tayi, barely detectable in human samples, became dominant in sick mice. A minor player in our gut turning the brain against itself. What changes everything: ↳ MS risk potentially measurable through stool samples ↳ Targeted antibiotics or bacteriophages possible ↳ Precision probiotics to outcompete harmful strains ↳ Prevention before symptoms, not just management The Multiplication Effect: 1 microbiome test = early risk detection 10 targeted interventions = personalized prevention 100 research centers refining = MS becoming preventable At scale = autoimmune diseases decoded through gut bacteria For decades, families watched one twin deteriorate while the other stayed healthy, wondering why their identical biology diverged. Now we know: the difference might be microscopic residents in their intestines. We spent 150 years treating MS as an inevitable brain disease. Now it might be a treatable gut imbalance. Because when identical DNA produces different diseases based on gut bacteria, you realise: The code for MS isn't just written in our genes. It's growing in our gut. Follow me, Dr. Martha Boeckenfeld for innovations where microscopic discoveries transform human health. ♻️ Share if you believe the next medical revolution lives in our gut, not our pharmacy. Resource: Kleinewietfeld, M., et al. (2024). Specific gut bacteria from multiple sclerosis patients modulate human T cell function and exacerbate symptoms in a mouse model. Proceedings of the National Academy of Sciences, 121(48), e2419689122.

Nature's Hacks for Success. Biomimicry might sound complex, but it's simply about learning from nature to enhance our designs. It's like learning from the best teacher—Mother Nature herself. Defined by the Biomimicry Institute, this approach guides us toward sustainable solutions by mimicking perfected patterns and strategies found in nature. Nature has already solved many of our challenges. So, why not apply its genius to our packaging designs? It offers patterns and relationships that inspire better, eco-friendly packaging designs—whether in structure or materials, designers can draw from nature's beauty, texture, and flow. We discover materials that are waterproof, breathable, flexible, and more—it's as if nature has already completed the heavy lifting of innovation, evolution, and adaptation for us. Think of the honeycomb structure in beehives—it's not only sturdy but also space-efficient. A great example of biomimicry in packaging design is the SIS bottle by Backbone Branding. Their designers draw inspiration from a flower's pistil to shape a two-litre juice bottle. The design not only stands out with its natural juice colour but also resolves many stacking, storage, and merchandising challenges through its interlocking form. Rooted in geometry with equilateral triangles, these bottles fit snugly together, saving space. Every aspect of the bottle, from its size and proportions to its lines and curves, has been carefully considered. Even the label has been specially designed to adhere to the bottle's irregular surface, eliminating the need for glue. Consider adding nature's strategy into your design process. It will help you close the loop and build a solution that resonates with the ecosystem we breathe in. Biomimicry enables us to develop sustainable systems rather than short-lived, isolated solutions that may soon become outdated. One thing's for sure, we stand at a crucial juncture in human history. The challenges ahead demand designers and innovators capable of creating resilient, adaptable solutions. Our path forward must consider the well-being of future generations across the planet. We must continually draw inspiration from nature and reciprocate by nurturing and preserving it. In doing so, we'll not only enrich our designs but also contribute to the greater ecosystem. Let nature continue to inspire us, and in return, let's contribute to its well-being—a cycle of respect and reciprocity where our designs and actions reflect a deep reverence for the natural world. Ready to take a cue from nature's playbook for your next packaging design? 📷Backbone Branding

Finland discovered bacteria that eat nuclear waste — cleaning radioactive sites in decades instead of millennia ☢️ Scientists at University of Helsinki identified extremophile bacteria in uranium mines that metabolize radioactive isotopes, converting dangerous nuclear waste into stable, non-radioactive compounds. These Deinococcus radiodurans bacteria survive radiation doses 3,000 times lethal to humans by rapidly repairing DNA damage while consuming radioactive materials for energy. The bioremediation process reduces nuclear waste half-life from 24,000 years to under 50 years. Finland is testing this bacterial treatment at the Onkalo nuclear repository, potentially solving the millennia-long storage problem plaguing nuclear energy. The bacteria are engineered to target specific isotopes like cesium-137 and strontium-90. This biological solution transforms nuclear waste management from geological burial to active bioremediation, making nuclear energy substantially safer and more sustainable.

Turning discarded pineapple waste into cleaning products 🌎 Turning agricultural waste into valuable products offers a practical way to address environmental and health challenges. Fuwa Biotech, a Vietnamese company, produces natural cleaning products from fermented pineapple skins, showing how local innovation can turn waste into scalable solutions. This approach reduces reliance on synthetic cleaners, which often contain harmful chemicals with long-term impacts on health and ecosystems. Fuwa Biotech’s process exemplifies the circular economy. By using fruit waste from local producers to create cleaning products and repurposing leftover materials as fertilizer, the company minimizes waste and generates value. This closed-loop system benefits both the environment and local communities. The company's enzyme-based cleaners offer a safer alternative to synthetic products that contribute to water pollution and air quality issues. Traditional cleaning products often contain chemicals that treatment facilities can't fully manage, leading to ecological harm. Fuwa’s natural approach addresses these problems with simple, effective solutions. The model is highly scalable. It relies on common agricultural by-products and basic fermentation, making it adaptable in regions with similar resources. As demand for sustainable, non-toxic products grows, this innovation could be replicated globally, supporting both environmental and economic goals. Fuwa Biotech’s work highlights how businesses can reduce resource consumption and pollution through circular practices. It shows that impactful solutions don’t require complex technology, just a commitment to rethink waste as a resource and scale practical innovations. #sustainability #sustainable #business #esg #climatechange #circulareconomy #circular

I am tremendously excited about the real-world impact of our latest publication on #AI #Biomarkers in Nature Medicine: https://lnkd.in/dv-7aS7Y Even in the US barely half of #lungcancer patients are tested for #EGFR mutations, for which targeted therapies readily exist. We have worked for many, many years now to try to overcome this gap with AI for H&E slides to offer patients a fast and cost-effective solution to get the right treatment. The point of this work is not only that we actually built it, but that Gabriele Campanella and Chad Vanderbilt organized a consortium and created the infrastructure for the first real-world, real-time deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection. 𝙋𝙧𝙤𝙨𝙥𝙚𝙘𝙩𝙞𝙫𝙚𝙡𝙮!   𝐌𝐞𝐞𝐭 𝐄𝐀𝐆𝐋𝐄 (EGFR AI Genomic Lung Evaluation): ✅ 𝟎.𝟖𝟗 𝐀𝐔𝐂 in a 𝐩𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 silent trial with clinical-grade performance. 🌍 Generalizes 𝐚𝐜𝐫𝐨𝐬𝐬 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐚𝐧𝐝 𝐜𝐨𝐧𝐭𝐢𝐧𝐞𝐧𝐭𝐬 with robustness and reproducibility. 🔬 Validated on 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐜𝐨𝐡𝐨𝐫𝐭𝐬, 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐢𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐢𝐨𝐧𝐬, 𝐚𝐧𝐝 𝐬𝐜𝐚𝐧𝐧𝐞𝐫𝐬. 🧪 𝟒𝟑% 𝐫𝐞𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐢𝐧 𝐫𝐚𝐩𝐢𝐝 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐭𝐞𝐬𝐭𝐬, preserving biopsy tissue for full genomic profiling. ⚡ 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐬 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐢𝐧 𝐮𝐧𝐝𝐞𝐫 𝟏 𝐡𝐨𝐮𝐫, compared to 2–3 weeks for NGS. 🚀 A foundational step toward regulatory approval and 𝐀𝐈-𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬.   We have worked on Computational Biomarkers in Pathology continuously for over a decade starting with AI for predicting SPOP in prostate cancer from H&E in 2015, but seeing everything come to fruition at such a scale in 2025 is very humbling. AI, when done right, can give real, tangible help to cancer patients. 𝑰𝒕 𝒊𝒔 𝒐𝒖𝒓 𝒓𝒆𝒔𝒑𝒐𝒏𝒔𝒊𝒃𝒊𝒍𝒊𝒕𝒚 𝒕𝒐 𝒎𝒂𝒌𝒆 𝒊𝒕 𝒂 𝒓𝒆𝒂𝒍𝒊𝒕𝒚! I am deeply grateful to everyone on this most amazing team: Gabriele Campanella, Neeraj Kumar, Ph.D., Swaraj Nanda, Siddharth Singi, Eugene Fluder, Ricky Kwan, Silke Mühlstedt, Nicole  Pfarr, Peter Schüffler, Ida Häggström, Noora Neittaanmäki, Levent Akyürek, Alina Basnet, Tamara Jamaspishvili, Michel Nasr, Matthew Croken, Fred Hirsch, Arielle Elkrief, Helena Yu, Orly Ardon, Greg Goldgof, Meera Hameed, Jane Houldsworth, Maria E. Arcila, Chad Vanderbilt #AI #ComputationalPathology #Biomarkers #AIinHealthcare #DigitalPathology #PrecisionMedicine #LungCancer #EGFR #NatureMedicine #FoundationModels #EAGLEModel #EAGLE #Oncology

What if we could clean the earth without a single machine or chemical, just with plants? That’s what phytoremediation does. It’s nature’s silent clean-up system where roots, leaves, and microbes work together to remove or neutralize contaminants from soil and water. This infographic reveals how plants do it: 🪴 Phytoextraction – Roots absorb metals, which move up and accumulate in leaves. 🌱 Phytostabilization – Roots lock pollutants in place, stopping their spread. 🍃 Phytodegradation – Enzymes in roots and leaves break down toxins into harmless compounds. 🌾 Phytostimulation – Root exudates feed microbes that degrade pollutants. 💨 Phytovolatilization – Plants release transformed gases safely through leaves. It’s slow but self-sustaining, turning plants into living detox units that restore balance over time. If soil can heal itself with a little biological help, maybe our systems can too. Would you support using phytoremediation in urban lands, mining zones, or farms? Let’s talk about where this could make the biggest impact. (Infographic re-illustrated by Jagdish Patel ©, adapted from the work of Favas et al., 2014, Phytoremediation of Soils Contaminated with Metals and Metalloids at Mining Areas, DOI: 10.5772/57469.) #SoilHealth #Phytoremediation

A study of 100 fields reveals that even after 20 years of organic management, soils contain up to 16 different pesticide compounds—disrupting microbial communities and undermining productivity long after application stops. Fields were analyzed across the agricultural spectrum—from conventional operations to established organic farms. Certified organic soils contained significant levels of atrazine, chloridazon, and carbendazim (a compound linked to declining reproductive health). The data contradicts what's on pesticide labels. Atrazine's official half-life (6-108 days) suggests quick breakdown, but field measurements show it persists for decades. Our current models dramatically underestimate how long these compounds actually remain in soil systems. This isn't just about chemical presence—it's about ecosystem function. The study identified a strong negative correlation between pesticide residues and beneficial soil microorganisms. Specifically, mycorrhizal fungi showed significant decline in pesticide-affected soils. A critical insight: pesticide presence better predicted soil biological health than traditional factors like fertilization practices. This suggests our understanding of what drives soil fertility needs revision to account for these long-term chemical impacts. The implications challenge organic certification frameworks, which focus on current management but may overlook historical contamination. A "chemical-free" farm might contain decades of persistent compounds affecting soil function regardless of current practices. Fortunately, biological systems offer powerful remediation solutions: MICROBIAL REMEDIATION: microbes that consume pesticides, enhanced by adding nutrients or introducing specialized degraders ENZYME PATHWAYS that transform compounds into less toxic forms PHYTOREMEDIATION: Plants like Kochia scoparia remediate atrazine through uptake and by stimulating specialized microbial communities at their roots The most effective method is an integrated approach. Plant-microbe partnerships create effective remediation systems where plants fuel microbial activity and microbes enhance plant growth—a synergistic relationship that accelerates cleanup beyond what either could achieve alone. This research challenges the conventional-to-organic transition period. Rather than passive waiting periods, conversion should include active remediation strategies tailored to specific field conditions and contamination profiles. Agricultural soils have much longer chemical memories than previously understood. Biological systems—microbes, enzymes, plants—offer sophisticated remediation pathways that can restore soil ecological function while maintaining productive agricultural systems.

I believe this is one of the most important papers in microbiome science. This new review in Neuron (Mitchell et al, 2025) systematically dismantles the gut microbiome-autism hypothesis through a critical assessment of published papers. I was honestly shocked by the numbers: Despite 100+ papers per year and $20-25M in annual NIH funding since 2018, the most cited studies have tiny sample sizes (n=20 for some), uncorrected multiple testing, and contradictory findings. Some report higher microbial diversity in autism, others lower, many find no difference. The taxa they report are inconsistent. When properly analyzed with sibling controls and adequate statistical power, associations largely disappear. The mouse model data is equally troubling. For example, a 2019 Cell paper claimed fecal transplants from autistic donors induced "autism-like behaviors" in mice. But when reanalyzed with proper statistics, the effects vanished. And it is really not clear how mouse behavior can model human autism. And these are not obscure papers - they are published in the most high profile journals and have thousands of citations each. Maybe it is not surprising that randomized controlled trials of probiotics show no consistent benefit for autism. As a result, we're watching well-intentioned science fuel a billion dollar "wellness" industry selling unproven interventions to vulnerable families. As a microbiome scientist, this really troubles me. Excellent research IS being done, and the microbiome holds real promise as a diagnostic and therapeutic tool. But these overhyped, methodologically weak studies cast a shadow over our entire field. The solution, in my opinion – and completely I agree with the authors on this – is to adopt the rigor that transformed human genomics: pre-specified hypotheses, adequate power, standardized protocols and pipelines, large sample sizes, statistical robustness, replication, and above all: resisting the hype machine. #microbiome #autism #scientificrigor #reproducibility #clinicaltrials